SnapShot: Multiple Myeloma

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.

Original languageEnglish (US)
Pages (from-to)678-678.e1
JournalCancer Cell
Volume28
Issue number5
DOIs
StatePublished - Nov 9 2015

Fingerprint

Multiple Myeloma
Plasma Cells
Disease Progression
Decision Making
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

SnapShot : Multiple Myeloma. / Braggio, Esteban D; Kortüm, K. Martin; Stewart, Alexander Keith.

In: Cancer Cell, Vol. 28, No. 5, 09.11.2015, p. 678-678.e1.

Research output: Contribution to journalArticle

Braggio, Esteban D ; Kortüm, K. Martin ; Stewart, Alexander Keith. / SnapShot : Multiple Myeloma. In: Cancer Cell. 2015 ; Vol. 28, No. 5. pp. 678-678.e1.
@article{a6d6c3cfb5a8450b9683a322ef9a5fc1,
title = "SnapShot: Multiple Myeloma",
abstract = "Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.",
author = "Braggio, {Esteban D} and Kort{\"u}m, {K. Martin} and Stewart, {Alexander Keith}",
year = "2015",
month = "11",
day = "9",
doi = "10.1016/j.ccell.2015.10.014",
language = "English (US)",
volume = "28",
pages = "678--678.e1",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - SnapShot

T2 - Multiple Myeloma

AU - Braggio, Esteban D

AU - Kortüm, K. Martin

AU - Stewart, Alexander Keith

PY - 2015/11/9

Y1 - 2015/11/9

N2 - Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.

AB - Multiple myeloma (MM) is a plasma cell malignancy characterized by a heterogeneous clinical presentation. Genetic abnormalities are not only key events in the origin and progression of the disease but are also useful tools for prognosis, risk stratification, and therapeutic decision making. Although still incurable, a revolution in the treatment of MM is currently ongoing, leading to a significant improvement of clinical outcome and survival. To view this SnapShot, open or download the PDF.

UR - http://www.scopus.com/inward/record.url?scp=84946559108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946559108&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2015.10.014

DO - 10.1016/j.ccell.2015.10.014

M3 - Article

C2 - 26555176

AN - SCOPUS:84946559108

VL - 28

SP - 678-678.e1

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 5

ER -